Results 1 to 1 of 1
08-29-2013, 12:10 PM #1
Cubist Pharmaceuticals Issues Voluntary Nationwide Recall of Four Lots of Cubicin (D
Lexington, Mass. – Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced it is voluntarily recalling four lots of CUBICIN® (daptomycin for injection) to the user level due to the presence of particulate matter found in a number of vials from these lots. No adverse events have been reported to date in association with a product complaint of vials containing glass particulates.
This notice provided by Budget101.com